PT969821E - Pastilhas tendo um nucleo revestido com um antifungico e um polimero - Google Patents

Pastilhas tendo um nucleo revestido com um antifungico e um polimero

Info

Publication number
PT969821E
PT969821E PT98919155T PT98919155T PT969821E PT 969821 E PT969821 E PT 969821E PT 98919155 T PT98919155 T PT 98919155T PT 98919155 T PT98919155 T PT 98919155T PT 969821 E PT969821 E PT 969821E
Authority
PT
Portugal
Prior art keywords
antifungal
pellets
polymer
nucleus coated
nucleus
Prior art date
Application number
PT98919155T
Other languages
English (en)
Inventor
Roger Petrus Gerebe Vandecruys
Valentin Florent Victor Conde
Paul Marie Victor Gilis
Jozef Peeters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT969821E publication Critical patent/PT969821E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
PT98919155T 1997-03-26 1998-03-18 Pastilhas tendo um nucleo revestido com um antifungico e um polimero PT969821E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP97200914 1997-03-26

Publications (1)

Publication Number Publication Date
PT969821E true PT969821E (pt) 2003-10-31

Family

ID=8228147

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98919155T PT969821E (pt) 1997-03-26 1998-03-18 Pastilhas tendo um nucleo revestido com um antifungico e um polimero

Country Status (31)

Country Link
EP (1) EP0969821B1 (pt)
JP (1) JP3608800B2 (pt)
KR (1) KR100520936B1 (pt)
CN (1) CN1206984C (pt)
AP (1) AP1227A (pt)
AT (1) ATE241969T1 (pt)
AU (1) AU734248B2 (pt)
BG (1) BG64434B1 (pt)
BR (1) BR9806174A (pt)
CA (1) CA2269501C (pt)
CY (1) CY2384B1 (pt)
CZ (1) CZ295502B6 (pt)
DE (1) DE69815316T2 (pt)
DK (1) DK0969821T3 (pt)
EE (1) EE03904B1 (pt)
ES (1) ES2201485T3 (pt)
HK (1) HK1022840A1 (pt)
HU (1) HU224217B1 (pt)
ID (1) ID21477A (pt)
IL (1) IL129575A (pt)
NO (1) NO325102B1 (pt)
NZ (1) NZ335364A (pt)
OA (1) OA11162A (pt)
PL (1) PL190566B1 (pt)
PT (1) PT969821E (pt)
RU (1) RU2218153C2 (pt)
SI (1) SI0969821T1 (pt)
SK (1) SK284813B6 (pt)
TR (1) TR199900990T2 (pt)
UA (1) UA60318C2 (pt)
WO (1) WO1998042318A1 (pt)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200002217T2 (tr) 1998-07-17 2001-02-21 Janssen Pharmaceutica N.V. Bir mantar ilacı ve bir polimer ile kaplanmış bir çekirdeğe sahip taneler.
ES2157731B1 (es) 1998-07-21 2002-05-01 Liconsa Liberacion Controlada Preparacion farmaceutica oral de un compuesto de actividad antifungica y procedimiento para su preparacion.
JP2003531099A (ja) 1999-03-24 2003-10-21 エフ エム シー コーポレーション 改良された水溶解度をもつ医薬製剤
KR100432949B1 (ko) * 2000-06-13 2004-05-31 코오롱제약주식회사 생체이용율이 향상된 이트라코나졸의 분립체 조성물과이를 이용한 이트라코나졸 제제 및 그 제조방법
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
CN100369904C (zh) 2001-02-14 2008-02-20 泰博特克药品有限公司 2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂
AR035819A1 (es) 2001-04-09 2004-07-14 Tibotec Pharm Ltd 2-(amino sustituido)-benzoxazol sulfonamidas, inhibidoras de la proteasa del hiv, composiciones farmaceuticas que comprenden dichos compuestos, metodo in vitro para inhibir la replicacion retroviral y uso de dichos compuestos en la fabricacion de medicamentos
PT1387842E (pt) 2001-05-11 2009-07-20 Tibotec Pharm Ltd 2-aminobenzoxazolsulfonamidas inibidoras de largo espectro da protease hiv
WO2002100407A1 (en) * 2001-06-12 2002-12-19 Smartrix Technologies Inc. Itraconazole granulations: pharmaceutical formulations for oral administration and method of preparing same
US8071133B2 (en) 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
EP1463502B1 (en) 2001-12-21 2011-07-13 Tibotec Pharmaceuticals Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
MY142238A (en) 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
SI1517899T1 (sl) 2002-05-17 2008-02-29 Tibotec Pharm Ltd Substituirani benzoksazol sulfonamidi sirokega spektra, ki so HIV proteazni inhibitorji
KR100994759B1 (ko) 2002-08-14 2010-11-16 티보텍 파마슈티컬즈 광역스펙트럼의 치환된 옥신돌 설폰아미드 hiv프로테아제 저해제
KR100557680B1 (ko) * 2002-11-23 2006-03-07 한국유나이티드제약 주식회사 이트라코나졸의 용해도 개선을 위한 펠렛제제 및 그제조방법
EP1438960B2 (en) * 2003-01-14 2012-12-19 Acino Pharma AG Compostion of itraconazole dispersed in a hydrophilic polymer having enhanced bioavailability
DK1438961T4 (da) * 2003-01-14 2014-11-17 Acino Pharma Ag Bioækvivalent sammensætning af itraconazol dispergeret i en hydrofil polymer
AU2004263130A1 (en) * 2003-08-06 2005-02-17 Nirmal Mulye Pharmaceutical composition containing water soluble drug
WO2005023242A1 (en) 2003-09-11 2005-03-17 Tibotec Pharmaceuticals Ltd. Entry inhibitors of the hiv virus
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
AR048650A1 (es) 2004-05-04 2006-05-10 Tibotec Pharm Ltd Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
AU2005244121B2 (en) 2004-05-07 2012-01-19 Sequoia Pharmaceuticals, Inc. Resistance-repellent retroviral protease inhibitors
CN1976930B (zh) 2004-05-17 2011-01-19 泰博特克药品有限公司 用作抗感染药物的6,7,8,9-取代的1-苯基-1,5-二氢吡啶并(3,2-b)吲哚-2-酮
JP4879889B2 (ja) 2004-05-17 2012-02-22 テイボテク・フアーマシユーチカルズ・リミテツド 4−置換−1,5−ジヒドロ−ピリド[3,2−b]インドール−2−オン
EA012330B1 (ru) 2004-05-17 2009-08-28 Тиботек Фармасьютикалз Лтд. 1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ
WO2007113290A1 (en) 2006-04-03 2007-10-11 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 3,4-dihydro-imidazo[4,5-b]pyridin-5-ones
KR20090065524A (ko) * 2006-09-04 2009-06-22 파나세아 바이오테크 리미티드 프로그래머블 부력전달기술
KR100809903B1 (ko) * 2006-09-05 2008-03-06 주식회사유한양행 안정화된 클로피도그렐-함유 입자, 그의 제조방법, 및 이를포함하는 약학 조성물
CN101283984B (zh) * 2007-04-12 2010-05-26 永胜药品工业股份有限公司 高生物使用率的经杀真菌剂和聚合物涂覆的核心微粒状物
JP2008280254A (ja) * 2007-05-08 2008-11-20 Everest Pharm Industrial Co Ltd 生体に使用される比率が高い、殺菌剤と重合物を塗粧してる核心微粒状物
US8313527B2 (en) 2007-11-05 2012-11-20 Allergan, Inc. Soft prosthesis shell texturing method
EP2224923A4 (en) 2007-11-28 2013-05-15 Sequoia Pharmaceuticals Inc COMPOSITIONS AND METHOD FOR INHIBITING ZYTOCHROM P450 2D6
US8906647B2 (en) 2008-02-21 2014-12-09 Sequoia Pharmaceuticals, Inc. Diamide inhibitors of cytochrome P450
US9050184B2 (en) 2008-08-13 2015-06-09 Allergan, Inc. Dual plane breast implant
US8877822B2 (en) 2010-09-28 2014-11-04 Allergan, Inc. Porogen compositions, methods of making and uses
US9205577B2 (en) 2010-02-05 2015-12-08 Allergan, Inc. Porogen compositions, methods of making and uses
US9138309B2 (en) 2010-02-05 2015-09-22 Allergan, Inc. Porous materials, methods of making and uses
SG174658A1 (en) 2010-04-01 2011-10-28 Theravida Inc Pharmaceutical formulations for the treatment of overactive bladder
ES2623475T3 (es) * 2010-05-11 2017-07-11 Allergan, Inc. Composiciones de porógenos, métodos para hacerlas y usos
US11202853B2 (en) 2010-05-11 2021-12-21 Allergan, Inc. Porogen compositions, methods of making and uses
US8679279B2 (en) 2010-11-16 2014-03-25 Allergan, Inc. Methods for creating foam-like texture
CN102100678B (zh) * 2011-02-18 2012-10-17 天津力生制药股份有限公司 伊曲康唑硫酸盐微丸及其制备方法
CA2895083A1 (en) 2012-12-13 2014-06-19 Allergan, Inc. Device and method for making a variable surface breast implant
US10092392B2 (en) 2014-05-16 2018-10-09 Allergan, Inc. Textured breast implant and methods of making same
AU2016388308B2 (en) * 2016-01-20 2022-08-04 Theravida, Inc. Methods and compositions for treating hyperhidrosis
BR112020020941A2 (pt) * 2018-04-16 2021-03-02 Bristol-Myers Squibb Company formulações apixaban
CN114767636B (zh) * 2022-04-11 2023-11-07 苏州中化药品工业有限公司 伊曲康唑微丸、制备方法及伊曲康唑微丸胶囊

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346123A1 (de) * 1983-12-21 1985-06-27 Janssen Pharmaceutica, N.V., Beerse Pharmazeutische praeparate von in wasser schwerloeslichen oder instabilen arzneistoffen und verfahren zu ihrer herstellung
GB8506792D0 (en) * 1985-03-15 1985-04-17 Janssen Pharmaceutica Nv Derivatives of y-cyclodextrin
PH30929A (en) * 1992-09-03 1997-12-23 Janssen Pharmaceutica Nv Beads having a core coated with an antifungal and a polymer.
JP2000514059A (ja) * 1996-06-28 2000-10-24 シェーリング コーポレイション トリアゾール抗真菌化合物を含む経口組成物

Also Published As

Publication number Publication date
NO992114D0 (no) 1999-04-30
SI0969821T1 (en) 2003-10-31
CN1206984C (zh) 2005-06-22
CY2384B1 (en) 2004-06-04
SK284813B6 (sk) 2005-12-01
AU734248B2 (en) 2001-06-07
KR20000052971A (ko) 2000-08-25
PL335542A1 (en) 2000-04-25
UA60318C2 (uk) 2003-10-15
AP1227A (en) 2003-11-24
ATE241969T1 (de) 2003-06-15
DE69815316T2 (de) 2004-04-29
HK1022840A1 (en) 2000-08-25
ES2201485T3 (es) 2004-03-16
IL129575A0 (en) 2000-02-29
BR9806174A (pt) 1999-10-19
NO992114L (no) 1999-08-26
NZ335364A (en) 2000-08-25
PL190566B1 (pl) 2005-12-30
CA2269501C (en) 2005-11-08
CN1244796A (zh) 2000-02-16
AP9901516A0 (en) 1999-06-30
BG64434B1 (en) 2005-02-28
JP3608800B2 (ja) 2005-01-12
HUP0002056A3 (en) 2001-01-29
DE69815316D1 (de) 2003-07-10
DK0969821T3 (da) 2003-09-15
IL129575A (en) 2004-06-20
EP0969821B1 (en) 2003-06-04
OA11162A (en) 2003-04-16
TR199900990T2 (xx) 1999-10-21
NO325102B1 (no) 2008-02-04
CZ295502B6 (cs) 2005-08-17
EE03904B1 (et) 2002-12-16
AU7210798A (en) 1998-10-20
CA2269501A1 (en) 1998-10-01
BG103356A (en) 2000-03-31
EP0969821A1 (en) 2000-01-12
JP2001520663A (ja) 2001-10-30
RU2218153C2 (ru) 2003-12-10
SK54499A3 (en) 2000-01-18
KR100520936B1 (ko) 2005-10-17
HU224217B1 (hu) 2005-06-28
EE9900453A (et) 2000-04-17
ID21477A (id) 1999-06-17
WO1998042318A1 (en) 1998-10-01
HUP0002056A2 (hu) 2000-12-28
CZ139899A3 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
PT969821E (pt) Pastilhas tendo um nucleo revestido com um antifungico e um polimero
FI950975A (fi) Antifungaalisella aineella ja polymeerilla päällystetyn ytimen käsittäviä helmiä
BR9608805A (pt) Composicão de revestimento tendo melhorada adesão a substrato e uso da mesma
IL137665A0 (en) Pellets having core coated with an antifungal and a polymer
ID28287A (id) Bahan dengan pelapis fotokatalitik
PT996701E (pt) Polialquilenoiminas alcoxiladas compativeis com lixivia
NO984980D0 (no) Uorganisk pigment belagt med uorganiske oksider
DE69824407D1 (de) Rufleitungs-identifizierung mit ortungsicon
DE69837848D1 (de) Eine brennstofzellenanordnung
NO975795D0 (no) Tilbakereflekterende merking med vidt tilbakereflekteringsområde
DE59813518D1 (de) Faktor x-analoge mit modifizierter proteasespaltstelle
DE69824784D1 (de) Brennstoffzelle
PT966287E (pt) Comprimidos de oxacarbazepina revestidos com pelicula
DE69811819D1 (de) Polymerbatterie
DE69823529D1 (de) Mehrstufige leitende schwarzmatrix
DE59802727D1 (de) Trägerkörper mit einer schutzbeschichtung
DE69620213D1 (de) [(3-alkoxy-phenoxy)-ethyl]-dialkylaminderivate und deren verwendung als lokalanaesthetika
ID24198A (id) Penanganan diabetes dengan tiazolidindion dan sulfonilurea
DE19882168T1 (de) Polyacetalharzzusammensetzung
PL358909A1 (en) Pellets having a core coated with a lipid lowering agent and a polymer
DE69836853D1 (de) Etablierte Mikrogliazellen
DE69523537D1 (de) Analog-Digital-Wandler mit schreibbarem Ergebnisregister
IT1298513B1 (it) Perno portabobina
ATE206793T1 (de) Betonverteilungs-arm mit artikulierenden teilen
DE69800087D1 (de) Betätigungsvorrichtung mit Drehscheibe